French Travelers' Knowledge of Risk of Acquiring ESBL-PE

Travel Medicine Clinical Trial

— MDR bacteria  

Official title:

Poor Knowledge Among French Travelers of the Risk of Acquiring Multidrug-resistant Bacteria During Travel

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03339947
• Other study ID #: 2016Ao006
• Status: Completed
• Phase: N/A
• First received: November 8, 2017
• Last updated: November 9, 2017
• Start date: January 1, 2016
• Est. completion date: June 1, 2016

Study information

• Verified date: November 2017
• Source: CHU de Reims
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, the investigators aimed to determine, among French travelers attending a consultation for travel medicine, patients level of knowledge about the risk of acquiring MRE.

Description:

Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, The investigators aimed to assess, among persons attending a consultation for travel medicine and international vaccines, patients level of knowledge regarding the risk of acquiring MRE, preventive behaviours and the need to inform health professionals that they had recently travelled if the patients require medical care after their return. A cross-sectional study was performed in the consultation for travel medicine and international vaccination in Reims University Hospital, France. All adult travellers who attended this consultation between January 2016 and May 2016 and who completed the questionnaire were included in the study. The questionnaire was completed before the planned travel. The travellers answered the questionnaires before seeing the physician.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 191
• Est. completion date: June 1, 2016
• Est. primary completion date: May 1, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult travellers who attended the consultation for travel medicine and international vaccination in Reims University Hospital

• Adult who completed the questionnaire

Related Conditions & MeSH terms

• Travel Medicine

Intervention

Other:
• Questionnaire

Locations

Country	Name	City	State
France	Damien JOLLY	Reims

Sponsors (1)

Lead Sponsor	Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

References & Publications (1)

Migault C, Kanagaratnam L, Nguyen Y, Lebrun D, Giltat A, Hentzien M, Bajolet O, Drame M, Bani-Sadr F. Poor knowledge among French travellers of the risk of acquiring multidrug-resistant bacteria during travel. J Travel Med. 2016 Oct 30;24(1). pii: taw073. Print 2016 Jul. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Level of knowledge regarding multidrug resistant Enterobacteriaceae	The questionnaire was completed before the planned travel and recorded information on the patient's knowledge of the definition of multidrug resistant bacteria (MDR), knowledge of the factors associated with acquiring MDR bacteria, consumption of antibiotics during previous travel, awareness of the need to inform health professionals about the recent trip in case of health problems after return, perceived need for more information about MDR bacteria, desired source of such information. The questions about knowledge were designed to be as simple as possible, with closed answers ('yes', 'no', 'don't know')	Day 1